Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Ramaekers

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
BMC Cancer|October 31, 2025
Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkersJaycey F Kelly, Iryna V Samarska, Bram Ramaekers, et al.
Scientific Reports|February 9, 2023
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the NetherlandsZakile A Mfumbilwa, Janneke A Wilschut, Martijn J H G Simons, et al.
BMJ Open|May 28, 2026
Risk-based selection for carotid revascularisation using the IMPROVE score versus standard care in symptomatic carotid artery disease: a model-based cost-effectiveness analysis using pooled-dataKelly P H Nies, Bram Ramaekers, Juul Bierens, et al.
The Journal of Investigative Dermatology|August 1, 2025
Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical OutcomeKarin van den Hurk, Kim Lommen, Louis Coussement, et al.
Advanced Drug Delivery Reviews|January 18, 2016
Decision support systems for personalized and participative radiation oncologyPhilippe Lambin, Jaap Zindler, Ben G L Vanneste, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
BMC Cancer|October 31, 2025
Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkersJaycey F Kelly, Iryna V Samarska, Bram Ramaekers, et al.
Scientific Reports|February 9, 2023
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the NetherlandsZakile A Mfumbilwa, Janneke A Wilschut, Martijn J H G Simons, et al.
BMJ Open|May 28, 2026
Risk-based selection for carotid revascularisation using the IMPROVE score versus standard care in symptomatic carotid artery disease: a model-based cost-effectiveness analysis using pooled-dataKelly P H Nies, Bram Ramaekers, Juul Bierens, et al.
The Journal of Investigative Dermatology|August 1, 2025
Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical OutcomeKarin van den Hurk, Kim Lommen, Louis Coussement, et al.
Advanced Drug Delivery Reviews|January 18, 2016
Decision support systems for personalized and participative radiation oncologyPhilippe Lambin, Jaap Zindler, Ben G L Vanneste, et al.
Pageof 4